Navigation Links
Number of Russian women smokers has doubled since Soviet collapse
Date:1/28/2008

The number of Russian women who smoke has more than doubled since the collapse of the Soviet Union, according to new research.

In 1992, seven per cent of women smoked, compared to almost 15 per cent by 2003. In the same period, the number of men who smoke has risen from 57 per cent to 63 per cent.

The researchers behind the study, published in the journal Tobacco Control, blame the privatisation of the previously state owned tobacco industry and the behaviour of the transnational tobacco companies (TTCs) for what they describe as a very worrying increase.

Between 1992 and 2000, TTCs such as Philip Morris, British American Tobacco and Japan Tobacco International invested approximately US$1.7 billion to gain a 60 per cent share of the privatised Russian tobacco market.

Tobacco advertising had simply not existed in the Soviet era. Yet as soon as the TTCs were there, it was rampant, say researchers. By the mid 1990s it was estimated that half of all billboards in Moscow and three quarters of plastic bags in Russia carried tobacco advertising.

There can be no doubt that the marketing tactics of Philip Morris, British American Tobacco and the like directly underpin this massive increase in smoking that spells disaster for health in Russia, said Dr Anna Gilmore from the University of Bath, who carried out the study with academics from the London School of Hygiene & Tropical Medicine and University College London, and has been researching tobacco control in the region for over seven years.

Following privatisation of the tobacco industry, TTCs invested heavily in developing the market, promoting smoking as part of the new western lifestyle.

They aggressively targeted women, young people and those living in cities with their marketing and distribution strategies. This is now directly reflected in the smoking patterns we are seeing. Until this point women in Russia had simply not smoked.

The situat
'/>"/>

Contact: Andrew McLaughlin
a.mclaughlin@bath.ac.uk
44-012-253-86883
University of Bath
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Battle Continues Over Vietnam PTSD Numbers
2. Record Number of Americans Lack Health Insurance
3. Growing Number of U.S. Kids Not Getting Needed Vaccinations
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. Number of Partners Doesnt Explain Gay HIV Rate
6. StemCyte, Inc. Ranked Number Six in Deloittes Technology Fast 50 Program for Los Angeles
7. Abortion Numbers Fall Worldwide
8. BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
9. Health Market Science Ranked Number Ten in Deloittes Technology Fast 50 Program for Greater Philadelphia
10. Huge numbers willing to go under knife to alter their appearance, study finds
11. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...quick to condemn hurtful comments, study suggests ...- Many people overestimate how strongly they would... , Sixty-three percent of study participants at...er for an experiment with a white person rather th...acist comments about the black person when he left...
(Date:1/8/2009)..., Md., Jan. 8 Hanger Or...announce that throughout the fourth quarter of 200... Center, Rocky Mountain Orthotic-Prosthetics Cente...nc., First Coast Orthotics & Prosthetics, and ...uisitions add patient care centers to existing mar...
(Date:1/8/2009)...ESDA, Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Int...e Company"), a leading independent American,provi... the People,s Republic,of China, today announced ...,China Conference, to be held in Shanghai on Janua...ina Conference will be held at the Pudong Shangri-...
(Date:1/8/2009)...Pa., Jan. 8 Cephalon, I...Baldino, Jr., Ph.D., Chairman and CEO will presen...held on January 13, 2009 in San Francisco, CA at a...n Time). The presentation will be webcast live on ...bsite. , , The webcast will be archived for on...
Breaking Medicine News(10 mins):Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...f the major causes of death among South Africa's y...s said. // Head of Policy Co-ordination and Advis...nzhe said they had conducted research and found th...e in HIV-AIDS-related deaths among young South Afr...
...complex mouth movements like blowing bubbles and l...age quickly, researchers say. // Katie Alcock and...tain studied 120 toddlers and carried out a series...s that might predict a child's ability to develop ...
...t transplants are on the decline. This is because ...y//. Hence the doctors at the Papworth Hospital in...rt was kept beating for five hours after it was re...n to receive a beating heart transplant was Michae...
...y of Adrian Bird, a molecular geneticist at the Un...23rd June// that the abnormally high levels of a p...s models of Rett Syndrome is causing its mitochond...rk overtime. Dr. Bird stated that this is the firs...
Other Medicine News:Health News:Latest In the Heart Transplant Field 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3
(Date:1/8/2009)...O, Jan. 8 If you are taking prescr...re not alone. Half of the people taking,prescript...ons are,varied -- they forget, are busy with othe.... Noncompliance has been called the Achilles heel ...verett Koop commented, "Drugs don,t,work in peopl...
(Date:1/8/2009)...reated at the initial dose in an ongoing Phase Ib ...ecline after three days , , Conference Call Tod...wire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (N...irst cohort of an ongoing Phase Ib clinical trial ...oside polymerase inhibitor. ANA598 was very well-...
(Date:1/7/2009)...enn., Jan. 7 Scientists...a high likelihood of relapse in children with acut...rchers caution that further research is needed to ...or IKAROS, lead to leukemia relapse, the finding...ostic tests to assess the risk of treatment failur...
(Date:1/7/2009)... Md., Jan. 7 ImQuest Life Sciences...ND application to the Food and Drug Administration...pyrimidinedione HIV inhibitor IQP-0410. ImQuest an...first quarter of 2009. IQP-0410 is a novel small m... nonnucleoside reverse transcriptase inhibitor (NN...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 1Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 2Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 3Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 4Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 1Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 2Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 3Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 4Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 5WallSt net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2249 1WallSt net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2249 2LeMaitre Vascular Appoints Russell D Hays to Its Board of Directors 2247 1LeMaitre Vascular Appoints Russell D Hays to Its Board of Directors 2247 2
...oved by FDA for long-term,maintenance treatment of...nebulized formoterol fumarate provides improved lu...nhanced patient quality of,life, and positive safe...ta presented at the,International Conference of th... Perforomist™ (formoterol fumarate),Inhalati...
...The U.S. Food and Drug Administration,(FDA) is awa...(rosiglitazone), a drug approved to treat type 2 d...ls have shown that there is a,potentially signific...-related deaths in patients taking Avandia. Howeve...term clinical trials of,Avandia, including an inte...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7FDA Issues Safety Alert on Avandia 2FDA Issues Safety Alert on Avandia 3
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Medicine Products: